Leave Your Message

Submit An Free Inquiry

Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

AI Helps Write
AI Helps Write

I-Acute Lymphoblastic Leukemia (T-ALL)-09

Isigulana: IMengmeng

Isini: Ibhinqa

Ubudala: Uneminyaka engama-21 ubudala

Ubuzwe: IsiTshayina

Uxilongo:I-Acute Lymphoblastic Leukemia (T-ALL)

    Umfundi waseyunivesithi ogama linguMengmeng waseYanjiao, eGuizhou, wafumana unyango olusebenzayo kwiBIOOCUS Medical Group.


    UMengmeng, ibhinqa, oneminyaka engama-21 ubudala, ufike kwikliniki yethu yangaphandle nge-22 kaJuni 2021, ediniwe kakhulu. Uvavanyo lwegazi oluqhelekileyo lubonise i-WBC 479×10^9/L. Uvavanyo olongezelelweyo lomongo lwaqinisekisa i-acute lymphoblastic leukemia (i-T-cell subtype). Wenziwe imijikelo emibini ye-chemotherapy, kodwa i-leukemia ayizange iphendule, ene-MRD (isifo esincinci esisele) kwi-56.01%, kwaye wayene-central nervous system leukemia.


    Ngomhla we-13 ku-Agasti, kwaqokelelwa ii-lymphocytes ze-autologous kwaye kwanikwa i-chemotherapy. Ngomhla wama-30 ku-Agasti, uMengmeng wafumana i-CD7 CAR-T cell infusion. Kwiiveki ezimbini emva kokufakwa, uvavanyo lwe-bone marrow lwabonisa ukuxolelwa ngokupheleleyo, ukungavumi kwe-MRD, kunye nokulawulwa kwe-leukemia yenkqubo ye-nervous system. Wafumana impendulo ye-grade 1 cytokine release syndrome (CRS) ngaphandle kwemiphumo emibi yenkqubo ye-nervous system.

    107xc

    inkcazo2

    Submit An Free Inquiry

    Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

    AI Helps Write